GI Dynamics (ASX:GID) has been granted a trading halt by the ASX...

  1. GI Dynamics (ASX:GID) has been granted a trading halt by the ASX this afternoon pending the company's ENDO Trial.

    GID is the developer of EndoBarrier®, the first endoscopically-delivered device therapy approved for the treatment of obese type 2 diabetes.

    The halt will remain in place until the opening of trade on Friday 31st July 2015, or earlier if an announcement is made to the market.

     

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.